US Stock MarketDetailed Quotes

SPRO Spero Therapeutics

Watchlist

1.610
+0.065+4.21%

Close May 2 16:00 ET

1.570
-0.040-2.48%

Post 19:29 ET

86.77MMarket Cap3.74P/E (TTM)

Spero Therapeutics Stock Forum

BadPaint

12 hours ago

$Sunshine Biopharma(SBFM.US)$ got 595 at .8213, i know its a low hold (i got a cannon aimed at $Spero Therapeutics(SPRO.US)$ at the moment. but damn! lets go!

Stock Region

Mar 19 09:13

Investment Bank Reiterates 'Buy' Rating For Therapeutics Company

Spero Therapeutics: A Biotech Investment Opportunity That You Shouldn't Miss.
In the ever-evolving world of biotechnology, one company that has recently caught the attention of investors and industry analysts alike is Spero Therapeutics (NASDAQ: $SPRO). HC Wainwright & Co., a reputable full-service investment bank, has reiterated its 'Buy' rating on the company's stock and maintained a price target of $7. This not only indicates the...

BadPaint

Mar 14 18:08

$Spero Therapeutics(SPRO.US)$

Moomoo AI

Mar 12 19:00

Spero Therapeutics' P/S lags behind the industry despite a strong price move. Its forecast for shrinking revenue and poor outlook justify the low P/S ratio. These conditions form a barrier for the share price at these levels.

Improved Revenues Required Before Spero Therapeutics, Inc. (NASDAQ:SPRO) Stock's 27% Jump Looks Justified

Moomoo AI

Feb 8 18:11

Ankit Mahadevia's recent sale below the current price of US$1.45 is seen as discouraging, suggesting satisfaction with a lower valuation. The lack of insider purchases over the last year and low level of insider ownership compared to most companies raises caution for potential investors.